Technology tamfitronics News in Brief Published: 17 June 2024 Nature Biotechnology volume42,page 824 (2024)Cite this article Amgens T cell engager Imdelltra (tarlatamab) has gained FDA accelerated approval for an aggressive type of cell lung cancer that is notoriously difficult to treat. The bispecific antibody is designed to bind both delta-like ligand 3 (DLL3) on small […]

Read More